Axogen Inc vs ProShares UltraPro S&P500 — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while ProShares UltraPro S&P500 trades at $154.52. Which is the better fit depends on your goals.
| AXGN | UPRO | |
|---|---|---|
Market Cap | $2.61B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $48.48 | $155.10 |
52-Week Low | $14.16 | $89.29 |
Enterprise Value | $2.52B | — |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.
Read more on UPRO →